Skip to main content
COVID-19

Medical Policy Revision: Radiofrequency Ablation of Peripheral Nerves to Treat Pain

Effective July 25, 2016, Horizon Blue Cross Blue Shield of New Jersey will change the way we consider certain claims for the use of radiofrequency (RF) energy to treat pain associated with plantar fasciitis or knee osteoarthritis.

Based on the guidelines of our medical policy, Radiofrequency Ablation of Peripheral Nerves to Treat Pain, (formerly titled Radiofrequency Therapy for Plantar Fasciitis and Heel Pain), radiofrequency ablation of peripheral nerves to treat pain associated with plantar fasciitis or knee osteoarthritis is considered investigational.

Review this revised policy in our online Medical Policy Manual.

Based on the guidelines of our revised medical policy, Radiofrequency Ablation of Peripheral Nerves to Treat Pain, AND the submitted diagnosis codes(s), CPT® code 64640 included on claims for services provided on and after July 25, 2016 may:

  • Be denied as an investigational, cosmetic or not medically necessary service.
  • Cause the claim to pend while information required to determine the medical necessity of this service is requested and reviewed.

Unless Horizon BCBSNJ gives written notice that all or part of the above changes have been cancelled or postponed, the changes will be applied to claims for dates of service on and after July 25, 2016.

CPT® is a registered trademark of the American Medical Association.

Published on: April 25, 2016, 08:00 a.m. ET
Last updated on: November 25, 2020, 00:21 a.m. ET